A Norwegian biotechnology company recently announced that the 21-month followup data from its clinical stage immunotherapy trials revealed promising results for mesothelioma patients who are also undergoing chemotherapy to treat their rare and deadly form of cancer caused by asbestos exposure. The results of the study show that at least half of the patients who…
Continue reading ›YOUR PEACE OF MIND”
Support for Mesothelioma and Asbestos Cancer Victims













